Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain 2Neoplasms 2Weight Loss 1Trigger Finger Disorder 1Prostatic Neoplasms 1Pituitary Neoplasms 1Patient Satisfaction 1Nose Neoplasms 1Mucositis 1Menorrhagia 1Median Neuropathy 1Lymphoma, Follicular 1Leiomyoma 1Hemorrhage 1Head and Neck Neoplasms 1Ganglion Cysts 1Esthesioneuroblastoma, Olfactory 1De Quervain Disease 1Cognitive Dysfunction 1Cachexia 1Adenomyosis 1Abnormalities, Radiation-Induced 1

Interventions

sargramostim 1Tomography, X-Ray Computed 1Salts 1Radionuclide Imaging 1Positron-Emission Tomography 1Moxibustion 1Magnetic Resonance Spectroscopy 1Ibuprofen 1Gemcitabine 1Fluorodeoxyglucose F18 1Fentanyl 1FPP(RGD)2 1Etoposide 1Endoscopic Mucosal Resection 1Electrocardiography 1Doxorubicin 1Doxepin 1Cisplatin 1Bevacizumab 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Esthesioneuroblastoma, Olfactory × Ibuprofen × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡